Earlier this year, a group of Resonandina investors visited several clinics across Latin America and the Caribbean. Seeing accessible diagnostics in action left a strong impression —serving visible patients in real need.
Expanding MRI access is not just about technology—it requires skilled professionals who can operate and interpret scans effectively.
This year marks a decade of accessible diagnostics at CDI-HAI, the imaging center established in partnership with Hospital Arco Iris and Resonandina in La Paz.
“That’s where van Bemmelen saw a business opportunity with meaningful impact: a medical leasing company (not an NGO), where diagnostics are purely a matter of operational costs—not capital investments. Clients pay per scan, under long-term contracts with a minimum volume as security. But without the usual real estate collateral or advance payments.”
“That’s where van Bemmelen saw a business opportunity with meaningful impact: a medical leasing company (not an NGO), where diagnostics are purely a matter of operational costs—not capital investments. Clients pay per scan, under long-term contracts with a minimum volume as security. But without the usual real estate collateral or advance payments.”
The lack of accessible diagnostic imaging is not just a healthcare issue—it’s an economic issue. Late-stage diagnoses mean higher treatment costs, increased hospital burden, and lost economic productivity.
An MRI machine is only as effective as the professionals who operate it. At St. Augustine’s Medical Services in St. Paul, Grenada, newly trained staff are now fully equipped to provide high-quality MRI diagnostics—bringing essential imaging services closer to home.
Did you know that Latin America and the Caribbean (LAC26) have only 3.6 MRI scanners per million people, compared to 20 per million in Europe? Access to critical diagnostics remains limited—a 5.5x growth potential.
As a Resonandina partner, CEDEMER has exceeded expectations—scanning and helping far more patients than initially estimated. Increased access to high-quality diagnostics means earlier detection, better treatment, and improved patient outcomes.
Europe invests ~€4,000 per capita in healthcare.
LAC: Just ~€1,155 per capita—with 32% paid out-of-pocket by patients.
For many in Latin America and the Caribbean, diagnostic imaging remains out of reach, because of high costs and limited public investment. As a result, millions go undiagnosed, leading to delayed treatments, worse outcomes, and higher long-term healthcare costs.
